Johnson & Johnson revenue and financials
$254.78Change from previous close: +0.73%Absolute change: +$1.85
In the fiscal year ended December 2025, Johnson & Johnson reported revenue of $94.19B (+6.05% year over year). Net income was $26.8B, a net margin of 28.5%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +6.05%
- 2025 vs 2024
- Net income growth
- +90.56%
- 2025 vs 2024
- Net margin
- 28.5%
- 2024: 15.8%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 25,310 | 24,062 | 24,564 | 23,993 | 23,743 | 21,893 | 22,520 | 22,471 | 22,447 | 21,383 | 21,395 | 21,351 |
| Cost of revenue | 8,016 | 8,086 | 7,812 | 7,291 | 7,613 | 7,349 | 6,908 | 6,757 | 6,867 | 6,504 | 6,515 | 6,380 |
| Gross profit | 17,294 | 15,976 | 16,752 | 16,702 | 16,130 | 14,544 | 15,612 | 15,714 | 15,580 | 14,879 | 14,880 | 14,971 |
| Selling, general and administrative | 6,253 | 5,854 | 6,613 | 5,784 | 5,752 | 4,981 | 6,226 | 5,253 | 5,625 | 5,027 | 5,564 | 5,143 |
| Research and development | 3,653 | 3,527 | 4,252 | 3,672 | 3,516 | 3,225 | 5,298 | 4,952 | 3,440 | 3,542 | 4,480 | 3,447 |
| Operating income | 7,388 | 6,595 | 5,887 | 7,246 | 6,862 | 6,338 | 4,088 | 5,509 | 6,515 | 6,310 | 4,836 | 6,381 |
| EBIT | 7,388 | 6,595 | 5,887 | 7,246 | 6,862 | 6,338 | 4,088 | 5,509 | 6,515 | 6,310 | 4,836 | 6,381 |
| EBITDA | 9,347 | 8,599 | 7,898 | 9,023 | 8,805 | 8,110 | 5,984 | 7,355 | 8,297 | 8,125 | 6,296 | 8,210 |
| Interest expense | 281 | 272 | 214 | 245 | 308 | 204 | 137 | 193 | 270 | 155 | 151 | 192 |
| Pre-tax income | 6,747 | 5,990 | 4,966 | 7,493 | 6,491 | 13,631 | 3,887 | 3,338 | 5,748 | 3,714 | 4,826 | 5,217 |
| Income tax | 1,213 | 755 | -150 | 2,341 | 954 | 2,632 | 456 | 644 | 1,062 | 459 | 694 | 908 |
| Net income | 5,534 | 5,235 | 5,116 | 5,152 | 5,537 | 10,999 | 3,431 | 2,694 | 4,686 | 3,255 | 4,049 | 26,028 |
| Net income to common shareholders | 5,534 | 5,235 | 5,116 | 5,152 | 5,537 | 10,999 | 3,431 | 2,694 | 4,686 | 3,255 | 4,049 | 26,028 |
| Basic EPS | 2.30 | 2.17 | 2.10 | 2.14 | 2.30 | 4.57 | 1.41 | 1.12 | 1.95 | 1.35 | 1.46 | 10.32 |
| Diluted EPS | 2.27 | 2.14 | 2.10 | 2.12 | 2.29 | 4.54 | 1.41 | 1.11 | 1.93 | 1.34 | 1.46 | 10.21 |
| Average shares (basic) | 2,407 | 2,409 | 2,439 | 2,408 | 2,406 | 2,407 | 2,427 | 2,407 | 2,407 | 2,408 | 2,767 | 2,523 |
| Average shares (diluted) | 2,440 | 2,445 | 2,439 | 2,429 | 2,419 | 2,424 | 2,427 | 2,428 | 2,422 | 2,430 | 2,767 | 2,550 |
| Dividend per share | 1.34 | 1.30 | 1.30 | 1.30 | 1.30 | 1.24 | 1.24 | 1.24 | 1.24 | 1.19 | 1.19 | 1.19 |
